(Q52832651)

8 May 2018

title

EFFECT OF HALOGENATED PYRIMIDINES AND THYMIDINE ON GROWTH OF L-CELLS AND A SUBLINE LACKING THYMIDINE KINASE. (English)

1 reference

8 May 2018

0 references

DUBBS DR

1

1 reference

8 May 2018

KIT S

series ordinal

2

1 reference

8 May 2018

language of work or name

English

0 references

publication date

1 January 1964

1 reference

8 May 2018

Experimental Cell Research

published in

1 reference

8 May 2018

volume

33

1 reference

8 May 2018

page(s)

19-28

1 reference

8 May 2018

describes a project that uses

L-M(TK-)

0 references

L-M(TK-)1D

0 references

cites work

Metabolism of uracil and 5-fluorouracil by drug-sensitive and by drug-resistant bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Chemotherapy of neoplastic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

5-Bromo-2'-deoxycytidine (BCDR). II. Studies with murine neoplastic cells in culture and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Studies on the biochemical pharmacology of 5-iodo-2'-deoxycytidine in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Effect of 5-iodo-2'-deoxyuridine on the biosynthesis of phosphorylated derivatives of thymidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Effects of 5-halogenated uracils on the growth of Escherichia coli and their incorporation into deoxyribonucleic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Biochemistry of vaccinia-infected mouse fibroblasts (strain L-M). I. Effects on nucleic acid and protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

DELETION OF THYMIDINE KINASE ACTIVITY FROM L CELLS RESISTANT TO BROMODEOXYURIDINE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Relative stability to thermal denaturation of deoxyribonucleic acid (DNA) preparations containing bromodeoxyuridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Induction of thymidine kinase by vaccinia-infected mouse fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

On the nature of a sparing effect by thymidine on the utilization of deoxycytidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

The metabolism of thymidine by murine leukemic lymphoblasts (L5178Y)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Amino acid requirements of the Novikoff hepatoma in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Studies concerning inhibition of the synthesis of deoxycytidine by phosphorylated derivatives of thymidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Feedback inhibition of thymidine kinase by thymidine triphosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Limited thymidine uptake in Escherichia coli due to an inducible thymidine phosphorylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Purification and properties of a pyrimidine deoxyriboside phosphorylase from Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

Possible Enzymic Mechanism for the Development of Resistance against Fluorouracil in Ascites Tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2864%2981006-5

10.1016/S0014-4827(64)81006-5

7 January 2021

Identifiers

DOI

1 reference

8 May 2018

PubMed ID

14109133

1 reference

8 May 2018